We are live on ! Find out more
EAM

Exane Asset Management Portfolio holdings

AUM $277M
1-Year Est. Return 26.27%
This Fund
S&P 500
This Quarter Est. Return
+6.98%
1 Year Est. Return
+26.27%
3 Year Est. Return
+77.5%
5 Year Est. Return
+80.92%
10 Year Est. Return
+419.8%
AUM
$319M
AUM Growth
+$88.3M
Cap. Flow
+$80.5M
Cap. Flow %
25.19%
Top 10 Hldgs %
48.57%
Holding
197
New
80
Increased
29
Reduced
13
Closed
68

Top Buys

Rank Stock Value
1
ASH icon
Ashland
ASH
+$17.8M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$17.3M
3
APD icon
Air Products & Chemicals
APD
+$16.8M
4
GILD icon
Gilead Sciences
GILD
+$12.5M
5
SHPG
Shire pic
SHPG
+$11M

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$17.7M
2
BIIB icon
Biogen
BIIB
+$11.8M
3
XL
XL Group Ltd.
XL
+$10.6M
4
QGEN icon
Qiagen
QGEN
+$9.04M
5
VR
Validus Hold Ltd
VR
+$7.69M

Sector Composition

Rank Sector Weight
1 Healthcare 33.85%
2 Materials 22.96%
3 Financials 10.26%
4 Technology 9.56%
5 Communication Services 5.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$123B
$20.2M 6.32%
325,141
-50,696
-13% -$3.01M
QGEN icon
2
Qiagen
QGEN
$8.35B
$19.7M 6.18%
492,310
-226,192
-31% -$9.04M
ALXN
3
DELISTED
Alexion Pharmaceuticals
ALXN
$19.2M 6%
+137,920
New +$17.3M
ASH icon
4
Ashland
ASH
$3.1B
$17.9M 5.62%
+213,898
New +$17.8M
APD icon
5
Air Products & Chemicals
APD
$66.1B
$17.3M 5.4%
+103,288
New +$16.8M
GILD icon
6
Gilead Sciences
GILD
$165B
$14.2M 4.46%
184,455
+166,055
+902% +$12.5M
UBS icon
7
UBS Group
UBS
$169B
$14.2M 4.45%
900,785
+493,705
+121% +$7.76M
SHPG
8
DELISTED
Shire pic
SHPG
$11.5M 3.6%
+63,400
New +$11M
TFCFA
9
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$10.6M 3.33%
229,658
+107,058
+87% +$4.91M
AXTA icon
10
Axalta
AXTA
$6.87B
$10.3M 3.22%
352,359
+67,777
+24% +$2.03M
SXT icon
11
Sensient Technologies
SXT
$4.67B
$9.3M 2.91%
+121,537
New +$8.67M
SHW icon
12
Sherwin-Williams
SHW
$79.8B
$9.28M 2.91%
+61,167
New +$9.06M
PPG icon
13
PPG Industries
PPG
$25.8B
$8.84M 2.77%
81,049
-33,608
-29% -$3.66M
COL
14
DELISTED
Rockwell Collins
COL
$8.73M 2.73%
62,119
+15,835
+34% +$2.18M
BMRN icon
15
BioMarin Pharmaceuticals
BMRN
$11.4B
$8.04M 2.52%
82,881
-32,305
-28% -$3.22M
CA
16
DELISTED
CA, Inc.
CA
$7.98M 2.5%
+180,755
New +$7.79M
BAC icon
17
Bank of America
BAC
$424B
$7.37M 2.31%
+250,000
New +$7.61M
ANDV
18
DELISTED
Andeavor
ANDV
$6.91M 2.16%
45,036
+44,612
+10,522% +$6.59M
EVHC
19
DELISTED
Envision Healthcare Holdings Inc
EVHC
$6.86M 2.15%
150,000
+70,000
+88% +$3.14M
PF
20
DELISTED
Pinnacle Foods, Inc.
PF
$5.83M 1.83%
90,000
+70,000
+350% +$4.63M
MITL
21
DELISTED
Mitel Networks Corporation
MITL
$5.55M 1.74%
503,600
+84,800
+20% +$932K
TMUS icon
22
T-Mobile US
TMUS
$212B
$5.42M 1.7%
+77,162
New +$4.96M
SYNT
23
DELISTED
Syntel Inc
SYNT
$5.28M 1.65%
+128,953
New +$5.16M
KLXI
24
DELISTED
KLX Inc.
KLXI
$5.02M 1.57%
+80,000
New +$4.93M
FCE.A
25
DELISTED
Forest City Realty Trust, Inc.
FCE.A
$4.52M 1.41%
+180,000
New +$4.39M
1
2 3 4 5

Similar funds

RCA
Ranch Capital Advisors Sarasota, Florida $277M AUM 22.08% 1-Year Est. Return
TAM
Townsend Asset Management Raleigh, North Carolina $277M AUM 16.26% 1-Year Est. Return
IIA
ICW Investment Advisors Scottsdale, Arizona $277M AUM 12.1% 1-Year Est. Return
TAP
Tounjian Advisory Partners Fort Myers, Florida $277M AUM 21.37% 1-Year Est. Return
TLA
Tanglewood Legacy Advisors Houston, Texas $276M AUM 16.97% 1-Year Est. Return
1NWS
1 North Wealth Services Annapolis, Maryland $277M AUM 15.28% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
EFP
Envision Financial Planning Memphis, Tennessee $276M AUM 10.87% 1-Year Est. Return

Exane Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Exane Asset Management held 197 positions worth $319M, up 38% from $231M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Exane Asset Management deployed $80.5M of net new capital in Q3 2018, opening 80 new positions and adding to 29 existing holdings. Its largest new stake was Ashland: 213,898 shares worth $17.9M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 37% a quarter earlier, followed by Materials and Financials.

On the sell side, the largest reduction was Qiagen, an estimated $9.04M trimmed.

  • Exane Asset Management's largest Q3 2018 buy was Ashland: 213,898 shares worth $17.9M.
  • Exane Asset Management added most to Gilead Sciences in Q3 2018, an estimated $12.5M increase.
  • Exane Asset Management's biggest Q3 2018 reduction was Qiagen, cutting an estimated $9.04M.
  • Exane Asset Management fully exited DuPont de Nemours in Q3 2018, selling an estimated $17.7M.
  • Exane Asset Management's ten largest holdings make up 49% of its $319M portfolio in Q3 2018.
  • Exane Asset Management opened 80 new positions and closed 68 in Q3 2018.
  • Exane Asset Management's portfolio value rose 38% quarter-over-quarter to $319M.

Based on Exane Asset Management's 13F filing for Q3 2018, filed 16 Nov 2018.